ClinicalTrials.govpublic full text
Safety and Efficacy of the Fully Humanized Anti - VEGF Monoclonal Antibody LYN00101
ovarian cancer, cervical cancer, colorectal cancer, stomach cancer, tolerability, safety, humanized anti-vegf monoclonal antibody, autocrine loops, lyn00101, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 877145
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.